Acadia Healthcare (ACHC) Fundamentals 2026 — Revenue Analysis | SniperIQ
Acadia Healthcare (ACHC) is a US-listed Healthcare company in Medical - Care Facilities with a market capitalization of
Acadia Healthcare (ACHC) has a market capitalization of approximately
Acadia Healthcare's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
Acadia Healthcare runs a net profit margin of -32.8%, a gross margin of 56.2%, and an operating margin of 11.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Acadia Healthcare reported revenue of
Acadia Healthcare does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Acadia Healthcare carries a debt-to-equity ratio of 1.36x and a current ratio of 1.71x, with a market beta of 0.64. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Acadia Healthcare (ACHC) the key facts are: market cap
Get Acadia Healthcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.